The AlphaLISA™ Human KEAP1 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, KEAP1, using Alpha Technology.
Kelch-like ECH-associated protein 1 (KEAP1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase involved in oxidative stress response. By promoting UPS mediated degradation, KEAP1 controls the expression level of key proteins such as NRF2, a transcription factor controlling the expression of antioxidant proteins. Sustained activation of NRF2 has been associated to cancers resistance, and its inhibition has been shown to dampen drugs resistance. Targeted protein degradation (TPD) uses small molecules to recruit E3 ubiquitin ligases into the proximity of the targeted protein of interest, promoting its ubiquitination-dependent degradation. Exploiting KEAP1 inhibitors for the development of bifunctional Proteolysis-targeting chimeras (PROTACs) is expected to expand the toolbox of E3 ligases to removing undesired proteins (e.g., NRF2) involved in various diseases such as cancers, neurodegenerative diseases, and metabolic disorders.
For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Assay Target |
KEAP1
|
---|---|
Assay Technology |
Alpha
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Method |
Alpha
|
Experimental Type |
In vitro
|
Shipping Conditions |
Shipped in Blue Ice
|
Target Species |
Human
|
Therapeutic Area |
Oncology
|
Unit Size |
500 Assay Points
|
Proteolysis Targeting Chimaeras (PROTACs) are innovative small molecules that revolutionize drug discovery. They consist of two...
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.